Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
about
The Blood Flow Shutdown Induced by Combretastatin A4 Impairs Gemcitabine Delivery in a Mouse HepatocarcinomaA novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI.The CAM cancer xenograft as a model for initial evaluation of MR labelled compounds.Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology.
P2860
Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Dynamic contrast-enhanced MRI ...... effects of combretastatin A4.
@en
Dynamic contrast-enhanced MRI ...... effects of combretastatin A4.
@nl
type
label
Dynamic contrast-enhanced MRI ...... effects of combretastatin A4.
@en
Dynamic contrast-enhanced MRI ...... effects of combretastatin A4.
@nl
prefLabel
Dynamic contrast-enhanced MRI ...... effects of combretastatin A4.
@en
Dynamic contrast-enhanced MRI ...... effects of combretastatin A4.
@nl
P2093
P2860
P356
P1433
P1476
Dynamic contrast-enhanced MRI ...... effects of combretastatin A4.
@en
P2093
A-C Fruytier
P2860
P304
P356
10.1002/NBM.3220
P577
2014-11-01T00:00:00Z